According to Zhitong Finance App, McPharmaceutical-B (02335.HK) issued an announcement. On October 15, 2026 (after the trading period), the board of directors resolved to adopt an H share incentive plan for shareholders' approval, and will seek permission from shareholders to repurchase H shares at the extraordinary shareholders' meeting held by the company.

Zhitongcaijing · 2d ago
According to Zhitong Finance App, McPharmaceutical-B (02335.HK) issued an announcement. On October 15, 2026 (after the trading period), the board of directors resolved to adopt an H share incentive plan for shareholders' approval, and will seek permission from shareholders to repurchase H shares at the extraordinary shareholders' meeting held by the company.